Cell culture models in developing nutrigenomics foods for inflammatory bowel disease

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 622, Issue 1-2, 2007, Pages 94-102

  Philpott, Martin ^a,c   Mackay, Laura ^a,c   Ferguson, Lynnette R ^a,c   Forbes, Davanea ^b,c   Skinner, Margot ^b,c  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b THE NEW ZEALAND INSTITUTE FOR PLANT AND FOOD RESEARCH LIMITED   (New Zealand)

^c Nutrigenomics New Zealand   (New Zealand)

Author keywords

High throughput screen; Inflammatory bowel disease; NOD2; Nutrigenomics; Single nucleotide polymorphism

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SALICYLATE SODIUM; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH THROUGHPUT SCREENING; MACROPHAGE; MODEL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUTRIGENOMICS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SITE DIRECTED MUTAGENESIS;

ANIMALS; CELLS, CULTURED; DIET; GENOTYPE; HUMANS; INFLAMMATORY BOWEL DISEASES; KIDNEY; MACROPHAGES; MICE; MODELS, BIOLOGICAL; MUTAGENESIS, SITE-DIRECTED; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; NUTRITION PHYSIOLOGY; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 34547650332     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2007.04.013     Document Type: Article

References (20)

1. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., Fiegler H., Shapero M.H., Carson A.R., Chen W., Cho E.K., Dallaire S., Freeman J.L., Gonzalez J.R., Gratacos M., Huang J., Kalaitzopoulos D., Komura D., MacDonald J.R., Marshall C.R., Mei R., Montgomery L., Nishimura K., Okamura K., Shen F., Somerville M.J., Tchinda J., Valsesia A., Woodwark C., Yang F., Zhang J., Zerjal T., Zhang J., Armengol L., Conrad D.F., Estivill X., Tyler-Smith C., Carter N.P., Aburatani H., Lee C., Jones K.W., Scherer S.W., and Hurles M.E. Global variation in copy number in the human genome. Nature 444 (2006) 444-454
2. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., Steinhart A.H., Abraham C., Regueiro M., Griffiths A., Dassopoulos T., Bitton A., Yang H., Targan S., Datta L.W., Kistner E.O., Schumm L.P., Lee A.T., Gregersen P.K., Barmada M.M., Rotter J.I., Nicolae D.L., and Cho J.H. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314 (2006) 1461-1463
3. Bauer M., Hamm A., and Pankratz M.J. Linking nutrition to genomics. Biol. Chem. 385 (2004) 593-596
4. Spielbauer B., and Stahl F. Impact of microarray technology in nutrition and food research. Mol. Nutr. Food Res. 49 (2005) 908-917
5. Dixon R.A., Gang D.R., Charlton A.J., Fiehn O., Kuiper H.A., Reynolds T.L., Tjeerdema R.S., Jeffery E.H., German J.B., Ridley W.P., and Seiber J.N. Applications of metabolomics in agriculture. J. Agric. Food Chem. 54 (2006) 8984-8994
6. Ferguson L.R., Shelling A.N., Browning B.L., Huebner C., and Petermann I. Genes, diet and inflammatory bowel disease. Mutat. Res. 622 (2007) 70-83
7. Haller D. Intestinal epithelial cell signalling and host-derived negative regulators under chronic inflammation: to be or not to be activated determines the balance towards commensal bacteria. Neurogastroenterol. Motil. 18 (2006) 184-199
8. Middleton Jr. E., Kandaswami C., and Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 52 (2000) 673-751
9. Ganesan S., Travis S.P.L., Ahmad T., and Jazrawi R. Role of tumor necrosis factor in Crohn's disease. Curr. Opin. Invest. Drugs 3 (2002) 1297-1300
10. Murillo L.S., Morre S.A., and Pena A.S. Toll-like receptors and NOD/CARD proteins: pattern recognition receptors are key elements in the regulation of immune response. Drugs Today 39 (2003) 415-438
11. Drouet C., Shakhov A.N., and Jongeneel C.V. Enhancers and transcription factors controlling the inducibility of the tumor necrosis factor-alpha promoter in primary macrophages. J. Immunol. 147 (1991) 1694-1700
12. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., and Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278 (2003) 8869-8872
13. Economou M., Trikalinos T.A., Loizou K.T., Tsianos E.V., and Ioannidis J.P.A. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am. J. Gastroenterol. 99 (2004) 2393-2404
14. Torok H.-P., Glas J., Tonenchi L., Bruennler G., Folwaczny M., and Folwaczny C. Crohn's disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology 127 (2004) 365-366
15. Linderson Y., Bresso F., Buentke E., Pettersson S., and D'Amato M. Functional interaction of CARD15/NOD2 and Crohn's disease-associated TNFalpha polymorphisms. Int. J. Colorectal Dis. 20 (2005) 305-311
16. Braat H., Stokkers P., Hommes T., Cohn D., Vogels E., Pronk I., Spek A., van Kampen A., van Deventer S., Peppelenbosch M., and Hommes D. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. J. Mol. Med. 83 (2005) 601-609
17. Watanabe T., Kitani A., Murray P.J., and Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5 (2004) 800-808
18. Schindler T., Bornmann W., Pellicena P., Miller W.T., Clarkson B., and Kuriyan J. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. Science 289 (2000) 1938-1942
19. Riedel R.F., and Febbo P.G. Epidermal growth factor receptor mutations predict sensitivity to gefitinib in patients with non-small-cell lung cancer. Future Oncol. 1 (2005) 461-466
20. Strober W., Murray P.J., Kitani A., and Watanabe T. Signalling pathways and molecular interactions of NOD1 and NOD2. Nat. Rev. Immunol. 6 (2006) 9-20